140 related articles for article (PubMed ID: 35468260)
1. First-line corticosteroids for Kawasaki disease: Pulse versus multiple dose.
Abrams JY; Ae R; Maddox RA; Schonberger LB; Nakamura Y; Belay ED
Pediatr Int; 2022 Jan; 64(1):e15112. PubMed ID: 35468260
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High-Risk Patients With Kawasaki Disease.
Ae R; Abrams JY; Maddox RA; Schonberger LB; Nakamura Y; Kuwabara M; Makino N; Matsubara Y; Kosami K; Sasahara T; Belay ED
J Am Heart Assoc; 2020 Sep; 9(17):e015308. PubMed ID: 32811256
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
Takekoshi N; Kitano N; Takeuchi T; Suenaga T; Kakimoto N; Suzuki T; Kada TT; Shibuta S; Tachibana S; Murayama Y; Yamaga H; Suzuki H
JAMA Netw Open; 2022 Jun; 5(6):e2216642. PubMed ID: 35696166
[TBL] [Abstract][Full Text] [Related]
4. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
Friedman KG; Gauvreau K; Baker A; Son MB; Sundel R; Dionne A; Giorgio T; De Ferranti S; Newburger JW
Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
[TBL] [Abstract][Full Text] [Related]
5. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
Chen S; Dong Y; Kiuchi MG; Wang J; Li R; Ling Z; Zhou T; Wang Z; Martinek M; Pürerfellner H; Liu S; Krucoff MW
JAMA Pediatr; 2016 Dec; 170(12):1156-1163. PubMed ID: 27749951
[TBL] [Abstract][Full Text] [Related]
6. Association between intravenous immunoglobulin dose and outcomes in patients with acute Kawasaki disease.
Michihata N; Suzuki T; Yoshikawa T; Saito K; Matsui H; Fushimi K; Yasunaga H
Eur J Pediatr; 2022 Oct; 181(10):3607-3615. PubMed ID: 35925450
[TBL] [Abstract][Full Text] [Related]
7. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
Wang J; Chen H; Shi H; Zhang X; Shao Y; Hang B; Xu Z; Rong X; Chu M; Qiu H
Pediatr Rheumatol Online J; 2020 Jun; 18(1):48. PubMed ID: 32527316
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
9. Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan.
Suzuki T; Michihata N; Hashimoto Y; Yoshikawa T; Saito K; Matsui H; Fushimi K; Yasunaga H
Eur J Pediatr; 2024 Jan; 183(1):415-424. PubMed ID: 37917176
[TBL] [Abstract][Full Text] [Related]
10. Status of treatment and outcome in Kawasaki disease in the Kinki area of Japan.
Tsuchihashi T; Kakimoto N; Kitano N; Suenaga T; Ikeda K; Izui M; Kobayashi N; Yoshimura K; Nakamura Y; Suzuki H;
Pediatr Int; 2022 Jan; 64(1):e15391. PubMed ID: 36256501
[TBL] [Abstract][Full Text] [Related]
11. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC; Aronoff SC
Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
[TBL] [Abstract][Full Text] [Related]
12. Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report.
Chu C; He L; Lin YX; Xie LP; Liu F
Pediatr Rheumatol Online J; 2021 Nov; 19(1):157. PubMed ID: 34749768
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
Zhao CN; Du ZD; Gao LL
Chin Med J (Engl); 2016 Apr; 129(8):922-8. PubMed ID: 27064036
[TBL] [Abstract][Full Text] [Related]
15. Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase.
Suzuki T; Michihata N; Aso S; Yoshikawa T; Saito K; Matsui H; Fushimi K; Yasunaga H
Eur J Pediatr; 2021 Nov; 180(11):3279-3286. PubMed ID: 33973071
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.
Miyata K; Miura M; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H
Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007191. PubMed ID: 33541111
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
Tanaka A; Inoue M; Hoshina T; Koga H
J Pediatr; 2021 Sep; 236():95-100. PubMed ID: 34019881
[TBL] [Abstract][Full Text] [Related]
19. Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG.
Goto R; Inuzuka R; Shindo T; Namai Y; Oda Y; Harita Y; Oka A
Clin Rheumatol; 2020 Dec; 39(12):3747-3755. PubMed ID: 32458247
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
Yanagimoto K; Nomura Y; Masuda K; Hirabayashi M; Morita Y; Yoshishige M; Ueno K; Eguchi T; Kawano Y
Int Arch Allergy Immunol; 2014; 164(2):83-8. PubMed ID: 24903098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
